Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: Possible implications

Pathology Research and Practice

Volumn 208, Issue 1, 2012, Pages 45-49

  Kren, Leos ^a   Fabian, Pavel ^b   Slaby, Ondrej ^b,c   Janikova, Andrea ^a   Soucek, Ondrej ^a   Sterba, Jaroslav ^a   Krenova, Zdenka ^a   Michalek, Jaroslav ^c   Kral, Zdenek ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Clinical stage; HLA E; Hodgkin lymphoma; Microenvironment

Indexed keywords

HLA E ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CELL TYPE; CLASSICAL HODGKIN LYMPHOMA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; MALE; MICROENVIRONMENT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84855810399     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.11.004     Document Type: Article

References (14)

1. Alvaro-Naranjo T., Lejeune M., Salvadó-Usach M.T., et al. Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients. Leuk. Lymphoma 2005, 46:1581-1591.
2. Bianchini M., Levy E., Zucchini C., et al. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int. J. Oncol. 2006, 29:83-94.
3. Coupel S., Moreau A., Hamidou M., et al. Expression and repase of soluble HLA-E is an. immunoregulatoryfeature of endothelial cell activation. Blood 2007, 109:2806-2814.
4. Derre L., Corvaisier M., Charreau B., et al. Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J. Immunol. 2006, 177:3100-3107.
5. Diepstra A., Poppema S., Boot M., et al. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma. Tissue Antigens 2008, 71:219-226.
6. King A., Allan D.S., Bowen M., et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 2000, 30:1623-1631.
7. Levy E.M., Bianchini M., Von Euw E.M., et al. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer. Int. J. Oncol. 2008, 32:633-641.
8. Malmberg K.J., Levitsky V., Norell H., et al. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD 94/NKG2A-dependent mechanism. J. Clin. Invest. 2002, 110:1515-1523.
9. Marin R., Ruiz-Cabello F., Pedrinaci S., et al. Analysis of HLA-E expression in human tumors. Immunogenetics 2003, 54:767-775.
10. Mazzarino P., Pietra G., Vacca P., et al. Identification of effector-memory CMV-specific T lymphocytes that killCMV-infected target cells in an HLA-E-restricted fashion. Eur. J. Immunol. 2005, 35:3240-3247.
11. Mingari M.C., Vitale C., Cambiaggi A., et al. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 1995, 7:697-703.
12. Nückel H., Rebmann V., Dürig J., et al. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005, 105:1694-1698.
13. Pietra G., Romagnani C., Moretta L., et al. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells. Curr. Pharm. Des. 2009, 15:3336-3344.
14. Sullivan L.C., Clements C.S., Rossjohn J., et al. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 2008, 72:415-424.